Immunoreactivity of patients with genital herpes underwent Covid-19

Please use this identifier to cite or link to this item: http://repository.tma.uz/xmlui/handle/1/3217

Full metadata record

DC Field	Value	Language
dc.contributor.author	Guli Ismailova, Firuza Mirodilova	-
dc.date.accessioned	2022-10-11T12:08:24Z	-
dc.date.available	2022-10-11T12:08:24Z	-
dc.date.issued	2022	-
dc.identifier.uri	http://repository.tma.uz/xmlui/handle/1/3217	-
dc.description.abstract	These data served as a basis for comprehensive immunomodulatory therapy with the domestic interferon inducer gozalidone and immunomodulators to persons who had contracted Covid-19 with RGH.	en_US
dc.language.iso	en	en_US
dc.publisher	Ljubljana	en_US
dc.title	Immunoreactivity of patients with genital herpes underwent Covid-19	en_US
dc.type	Thesis	en_US
Appears in Collections:	Thesis, Articles

Files in This Item:

File	Description	Size	Format
1. Исмаилова Г.А..pdf	Immunoreactivity of patients with genital herpes underwent Covid-19.	915.25 kB	Adobe PDF	View/Open

DSpace JSPUI